GPCR
Price
$67.06
Change
-$0.38 (-0.56%)
Updated
Dec 12 closing price
Capitalization
4.64B
Intraday BUY SELL Signals
OCUL
Price
$14.56
Change
-$0.11 (-0.75%)
Updated
Dec 12 closing price
Capitalization
3.1B
86 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GPCR vs OCUL

Header iconGPCR vs OCUL Comparison
Open Charts GPCR vs OCULBanner chart's image
Structure Therapeutics
Price$67.06
Change-$0.38 (-0.56%)
Volume$1.5M
Capitalization4.64B
Ocular Therapeutix
Price$14.56
Change-$0.11 (-0.75%)
Volume$2.83M
Capitalization3.1B
GPCR vs OCUL Comparison Chart in %
GPCR
Daily Signal:
Gain/Loss:
OCUL
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
GPCR vs. OCUL commentary
Dec 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GPCR is a Hold and OCUL is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 14, 2025
Stock price -- (GPCR: $67.44 vs. OCUL: $14.67)
Brand notoriety: GPCR and OCUL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GPCR: 129% vs. OCUL: 119%
Market capitalization -- GPCR: $4.64B vs. OCUL: $3.1B
GPCR [@Biotechnology] is valued at $4.64B. OCUL’s [@Biotechnology] market capitalization is $3.1B. The market cap for tickers in the [@Biotechnology] industry ranges from $114.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GPCR’s FA Score shows that 0 FA rating(s) are green whileOCUL’s FA Score has 0 green FA rating(s).

  • GPCR’s FA Score: 0 green, 5 red.
  • OCUL’s FA Score: 0 green, 5 red.
According to our system of comparison, GPCR is a better buy in the long-term than OCUL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GPCR’s TA Score shows that 5 TA indicator(s) are bullish while OCUL’s TA Score has 6 bullish TA indicator(s).

  • GPCR’s TA Score: 5 bullish, 3 bearish.
  • OCUL’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both GPCR and OCUL are a good buy in the short-term.

Price Growth

GPCR (@Biotechnology) experienced а +105.30% price change this week, while OCUL (@Biotechnology) price change was +18.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.68%. For the same industry, the average monthly price growth was +4.10%, and the average quarterly price growth was +64.61%.

Reported Earning Dates

OCUL is expected to report earnings on Mar 09, 2026.

Industries' Descriptions

@Biotechnology (+0.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GPCR($4.64B) has a higher market cap than OCUL($3.1B). GPCR YTD gains are higher at: 148.673 vs. OCUL (71.780). OCUL has higher annual earnings (EBITDA): -233.54M vs. GPCR (-246.42M). GPCR has more cash in the bank: 799M vs. OCUL (345M). GPCR has less debt than OCUL: GPCR (7.09M) vs OCUL (77M). OCUL has higher revenues than GPCR: OCUL (55.8M) vs GPCR (0).
GPCROCULGPCR / OCUL
Capitalization4.64B3.1B149%
EBITDA-246.42M-233.54M106%
Gain YTD148.67371.780207%
P/E RatioN/AN/A-
Revenue055.8M-
Total Cash799M345M232%
Total Debt7.09M77M9%
FUNDAMENTALS RATINGS
OCUL: Fundamental Ratings
OCUL
OUTLOOK RATING
1..100
24
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
95
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GPCROCUL
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
88%
Bearish Trend 3 days ago
80%
Momentum
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
84%
MACD
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
73%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 6 days ago
87%
Bullish Trend 6 days ago
78%
Declines
ODDS (%)
Bearish Trend 11 days ago
87%
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
78%
Aroon
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
GPCR
Daily Signal:
Gain/Loss:
OCUL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MINJX47.520.42
+0.89%
MFS International Intrinsic Value R6
MJRFX23.150.20
+0.87%
BlackRock Mid-Cap Value K
MOSYX10.190.08
+0.79%
MassMutual Overseas Svc
ETAGX61.980.30
+0.49%
Eventide Gilead A
DHINX13.270.02
+0.15%
Centre Global Infrastructure Investor

GPCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, GPCR has been closely correlated with WVE. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if GPCR jumps, then WVE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GPCR
1D Price
Change %
GPCR100%
-2.18%
WVE - GPCR
71%
Closely correlated
-17.20%
KYMR - GPCR
51%
Loosely correlated
-2.31%
FULC - GPCR
50%
Loosely correlated
-7.25%
OCUL - GPCR
50%
Loosely correlated
-4.80%
TERN - GPCR
43%
Loosely correlated
+5.56%
More

OCUL and

Correlation & Price change

A.I.dvisor indicates that over the last year, OCUL has been loosely correlated with WVE. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if OCUL jumps, then WVE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCUL
1D Price
Change %
OCUL100%
-4.80%
WVE - OCUL
56%
Loosely correlated
-17.20%
NRIX - OCUL
54%
Loosely correlated
-2.75%
KYMR - OCUL
54%
Loosely correlated
-2.31%
DNLI - OCUL
53%
Loosely correlated
-1.14%
IDYA - OCUL
52%
Loosely correlated
-0.24%
More